[go: up one dir, main page]

SV2002000459A - Derivados de sulfonamidas ref. x-13840 - Google Patents

Derivados de sulfonamidas ref. x-13840

Info

Publication number
SV2002000459A
SV2002000459A SV2001000459A SV2001000459A SV2002000459A SV 2002000459 A SV2002000459 A SV 2002000459A SV 2001000459 A SV2001000459 A SV 2001000459A SV 2001000459 A SV2001000459 A SV 2001000459A SV 2002000459 A SV2002000459 A SV 2002000459A
Authority
SV
El Salvador
Prior art keywords
sulfonamids
ref
derivatives
dolences
psychiatric
Prior art date
Application number
SV2001000459A
Other languages
English (en)
Inventor
Macklin Brian Arnold
Thomas John Bleisch
George William Cuff
Paul Leslie Ornstein
Dennis Michael Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV2002000459A publication Critical patent/SV2002000459A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE FORMULA I, VER FORMULA, O A UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, QUE SON UTILES PARA EL TRATAMIENTO DE DOLENCIAS ASOCIADAS CON HIPOFUNCION DE GLUTAMATO, COMO TRASTORNOS PSIQUIATRICOS Y NEUROLOGICOS.
SV2001000459A 2000-05-19 2001-05-18 Derivados de sulfonamidas ref. x-13840 SV2002000459A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20600300P 2000-05-19 2000-05-19

Publications (1)

Publication Number Publication Date
SV2002000459A true SV2002000459A (es) 2002-07-03

Family

ID=22764580

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000459A SV2002000459A (es) 2000-05-19 2001-05-18 Derivados de sulfonamidas ref. x-13840

Country Status (24)

Country Link
US (1) US20030225163A1 (es)
EP (1) EP1311474A1 (es)
JP (1) JP2003534316A (es)
KR (1) KR20030007644A (es)
CN (1) CN1429205A (es)
AR (1) AR035915A1 (es)
AU (1) AU2001259053A1 (es)
BR (1) BR0110874A (es)
CA (1) CA2409830A1 (es)
CZ (1) CZ20023797A3 (es)
DZ (1) DZ3343A1 (es)
EA (1) EA200201234A1 (es)
EC (1) ECSP014078A (es)
HR (1) HRP20020918A2 (es)
HU (1) HUP0302255A3 (es)
IL (1) IL152156A0 (es)
MX (1) MXPA02010020A (es)
NO (1) NO20025459D0 (es)
PE (1) PE20020052A1 (es)
PL (1) PL358180A1 (es)
SK (1) SK16312002A3 (es)
SV (1) SV2002000459A (es)
WO (1) WO2001090057A1 (es)
ZA (1) ZA200208749B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US6984756B2 (en) 2000-05-19 2006-01-10 Eli Lilly And Company Process for preparing biphenyl compounds
ES2225558T3 (es) 2000-06-13 2005-03-16 Eli Lilly And Company Derivados de sulfonamida.
EP1438036A2 (en) * 2001-10-12 2004-07-21 Eli Lilly And Company Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
EP2102153A1 (en) * 2006-12-11 2009-09-23 Eli Lilly & Company Ampa receptor potentiators
BR112015031249A2 (pt) 2013-06-13 2017-07-25 Veroscience Llc método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525099B1 (en) * 1998-07-31 2003-02-25 Eli Lilly And Company N-substituted sulfonamide derivatives

Also Published As

Publication number Publication date
CA2409830A1 (en) 2001-11-29
EP1311474A1 (en) 2003-05-21
HUP0302255A2 (hu) 2003-11-28
SK16312002A3 (sk) 2003-05-02
NO20025459L (no) 2002-11-14
PE20020052A1 (es) 2002-02-02
CN1429205A (zh) 2003-07-09
AR035915A1 (es) 2004-07-28
IL152156A0 (en) 2003-05-29
CZ20023797A3 (cs) 2003-04-16
NO20025459D0 (no) 2002-11-14
KR20030007644A (ko) 2003-01-23
ECSP014078A (es) 2002-02-25
BR0110874A (pt) 2003-02-11
JP2003534316A (ja) 2003-11-18
PL358180A1 (en) 2004-08-09
WO2001090057A1 (en) 2001-11-29
AU2001259053A1 (en) 2001-12-03
DZ3343A1 (fr) 2001-11-29
HRP20020918A2 (en) 2004-02-29
MXPA02010020A (es) 2003-02-12
ZA200208749B (en) 2004-01-30
US20030225163A1 (en) 2003-12-04
HUP0302255A3 (en) 2005-11-28
EA200201234A1 (ru) 2003-04-24

Similar Documents

Publication Publication Date Title
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
SV2002000356A (es) Nuevos derivados de piperazina ref. pc10770aixn/bb
SV2004001291A (es) Alquinos como inhibidores de metaloproteinasa de matriz ref. pc20536
SV2002000478A (es) Derivados de tiofeno utiles como anticancerosos ref. pc10795aagl/bb
PA8501801A1 (es) Inhibidores triciclicos de polimerasas (adp - polirribosas)
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
PA8578601A1 (es) Derivados de 2,2- difenil-benzodioxol
UY27551A1 (es) Derivados de benzotiazol
BG106585A (en) Kinase inhibitors as therapeutic agents
PA8680701A1 (es) Derivados de oxindol
DOP2006000170A (es) Nuevos derivados de espirocromanona
GT200300177A (es) Terapia de combinacion para enfermedades hiperproliferativas
MXPA04006184A (es) Compuestos derivados de 1h-pirazolilo, para el uso en enfermedades asociadas con el receptor 5-ht2c.
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
CR9721A (es) Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos
ECSP024403A (es) Derivados de sulfonil-pirrolidina utiles para el tratamiento de desordenes neurologicos
HN2003000063A (es) Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades.
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
SV2004001416A (es) Compuestos azapoliciclicos condensados con arilo ref. pc23246
DE60104697D1 (de) Sulfonamid-derivate
SV2002000459A (es) Derivados de sulfonamidas ref. x-13840
BRPI0317188A8 (pt) novo derivado de 2,4-diamino-1,3,5-triazina
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ECSP014079A (es) Derivados de sulfonamida
GT200300066A (es) Derivados de ciclopenteno

Legal Events

Date Code Title Description
FD Lapse